Hepatitis Bs antigen (HBsAg) during pregnancy

Area of Science:

• Hepatology
• Virology
• Obstetrics

Background:

• Hepatitis B virus (HBV) infection during pregnancy poses risks for both mother and child.
• Vertical transmission of HBV from mother to infant is a significant concern.
• Understanding transmission patterns is crucial for effective management and prevention.

Observation:

• Three pregnant patients with hepatitis B were monitored.
• Infant outcomes varied: one infant tested positive for hepatitis B surface antigen (HBsAg) at 3 months, another at 6 weeks.
• The third infant tested negative for HBsAg at birth.

Findings:

• Maternal hepatitis B infection can lead to infant HBV exposure and potential infection.
• The timing of HBsAg detection in infants post-birth can vary.
• Negative HBsAg status at birth does not entirely rule out later infection.

Implications:

• Early detection and monitoring of HBsAg in infants born to infected mothers are essential.
• Management strategies should consider the risk of vertical transmission.
• Further research into optimal preventative measures and treatment protocols for pregnant women with hepatitis B is warranted.